02487.HK
Cutia Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 1.76
+0.57%Margins
Gross margin
55.1%
EBITDA margin
-115.7%
EBIT margin
-125.1%
Net margin
-125.7%
FCF margin
-127.4%
-87.4%
Return on equity
-59.2%
Return on assets
-64.0%
Return on invested capital
0.51x
Asset turnover
-HKD 873.2M
Cash from operations
HKD 2.52
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025